Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 2Mentions an overnight / inpatient stay

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

National Institute on Aging (NIA) · NCT07721467

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 65–120 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 2
Target enrollment
200
US sites recruiting
1
Study start
October 29, 2026
Record last updated
October 26, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Background

Normal aging, as well as dementias such as Alzheimer s disease, can cause changes in the brain that affect memory, attention, and thinking. Researchers want to know if regular mental tasks (cognitive training) can improve brain function in older adults. They also want to know if psilocybin, a compound found in certain mushrooms, can further support improved brain function.

Objective

To learn how regular cognitive training, with or without psilocybin, can improve brain health in older adults.

Eligibility

People aged 65 years and older with mild cognitive impairment or early-stage Alzheimer s disease. Healthy older adults with normal cognition are also needed.

Design

Participants will be screened. They will have a test of their heart function and an imaging scan. They will have mental health screening and tests of their thinking and memory. They will practice brain-training tasks on a tablet.

Participants will be divided into 2 groups: 1 will have cognitive training plus psilocybin; 1 will have cognitive training only.

Those having cognitive training only will have 5 or 6 clinic visits. They will take the tablet home to practice brain training daily. They will wear a device to measure brain waves as they sleep; they may have 1 overnight stay in the clinic, or they may wear the device at home. Imaging scans and other tests will be repeated at each visit.

Those taking psilocybin will have up to 9 clinic visits. In addition to the visits for cognitive training, they will take 1 psilocybin capsule by mouth 2 weeks apart (the second dose is optional). They will remain in the clinic for 24 hours after each dose.

Being studied: Psilocybin; Cognitive Training

Conditions: Alzheimer's Disease

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria
  • Pending Web Eligibility

Recruiting US locations

  • National Institute of Aging, Clinical Research Unit

    Baltimore, MD 21224

    Site contact: Dimitrios Kapogiannis, M.D. · 667-391-0063 · kapogiannisd@mail.nih.gov

Study contacts (from the official record)

  • Sierra D Kunkosi · (410) 350-3941 · sierra.kunkoski@nih.gov
  • Dimitrios I Kapogiannis, M.D. · (667) 391-0063 · kapogiannisd@mail.nih.gov
All neurology studies in Maryland →
Neuroplasticity Enhancement From Cognitive Training Reinforced by… (NCT07721467) | Bored Studies